University of California San Francisco
UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research. The IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — is a new initiative that provides funding for early-career scientists whose research focuses on cancer immunology and immunotherapy. Blaisdell is one of nine IGNITE fellows selected for this inaugural award.
MRIs are among the most accurate imaging tests used to diagnose brain tumors, and MRI-based monitoring of tumors guides critical treatment decisions. The clinical standard for measuring tumors often relies on either subjective evaluation or simplified two-dimensional (2D) measurements.